TDF:Tenofovir, Urine beta2microglobulin
Showing 1 - 25 of 5,725
Urine mtDNA and Beta 2-MG to Predict Acute Kidney Injury for
Recruiting
- Surgery-Complications
- +2 more
-
Wonju, Gangwon, Korea, Republic ofWonju Severance Christian Hospital
Aug 9, 2022
Kidney Function Through Combination of Renal Biomarkers in Blood
Completed
- Renal Biomarkers in Children
- blood test for renal biomarkers (creatinine, cystatin C, Neutrophil gelatinase-associated lipocalin, beta-trace protein, beta-2 microglobulin, uromodulin)
- urine test for renal biomarkers (creatinine, cystatin C, Neutrophil gelatinase-associated lipocalin, beta-trace protein beta-2 microglobulin, uromodulin, albumin)
-
Basel, SwitzerlandUniversity of Basel Children's Hospital
Jul 13, 2020
HIV Trial in Worldwide (DTG + 3TC, TAF based regimen (TBR))
Completed
- HIV Infections
- DTG + 3TC
- TAF based regimen (TBR)
-
Phoenix, Arizona
- +132 more
Jun 27, 2022
Pre-Exposure Prophylaxis of HIV-1 Infection Trial in Worldwide (F/TAF, F/TDF, F/TAF Placebo)
Active, not recruiting
- Pre-Exposure Prophylaxis of HIV-1 Infection
- F/TAF
- +3 more
-
Beverly Hills, California
- +92 more
Jun 28, 2022
Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (Dolutegravir (DTG), Lamivudine (3TC), Tenofovir disoproxil
Active, not recruiting
- Infection, Human Immunodeficiency Virus
- HIV Infections
- Dolutegravir (DTG)
- +2 more
-
Phoenix, Arizona
- +89 more
Jun 27, 2022
Chronic Hepatitis b Trial in Seoul (Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate)
Completed
- Chronic Hepatitis b
- Tenofovir Alafenamide
- Tenofovir Disoproxil Fumarate
-
Seoul, Korea, Republic ofAsan Medical Center
Mar 25, 2021
Human Immunodeficiency Virus Type 1 Trial in Worldwide (D/C/F/TAF, Boosted Protease Inhibitor (bPI), FTC/TDF)
Completed
- Human Immunodeficiency Virus Type 1
- D/C/F/TAF
- +2 more
-
Phoenix, Arizona
- +81 more
Nov 25, 2021
Risk Reduction Trial in Thika (PUMA)
Active, not recruiting
- Risk Reduction
- PUMA
-
Thika, Near Nairobi, KenyaKEMRI Partners in Health and Research Development (PHRD), Thika
Jan 11, 2023
Acute Kidney Injury Trial in Singapore (AKI risk screening using RenaFAST POCT test kits)
Recruiting
- Acute Kidney Injury
- AKI risk screening using RenaFAST POCT test kits
-
Singapore, SingaporeNational University Hospital
Nov 6, 2023
Renal Insufficiency, Tenofovir Trial in Bangkok Noi (Switching to Tenofovir Alafenamide)
Recruiting
- Renal Insufficiency
- Tenofovir
- Switching to Tenofovir Alafenamide
-
Bangkok Noi, Bangkok, ThailandFaculty of Medicine Siriraj Hospital, Mahidol University
Mar 7, 2022
Medication Adherence, HIV Trial in Pittsburgh (dolutegravir oral tablet 50mg, emtricitabine/tenofovir alafenamide oral tablet
Completed
- Medication Adherence
- HIV
- dolutegravir oral tablet 50mg
- +3 more
-
Pittsburgh, PennsylvaniaHIV/AIDS Clinical Research Unit / University of Pittsburgh
Mar 2, 2022
Hepatitis C, HIV Coinfection Trial in Aurora (TDF with a boosted protease inhibitor, TAF with a boosted protease inhibitor, TAF
Completed
- Hepatitis C
- HIV Coinfection
- TDF with a boosted protease inhibitor
- +2 more
-
Aurora, ColoradoUniversity of Colorado Hospital
Jan 21, 2021
Chronic Hepatitis b, Tenofovir Alafenamide Fumarate Trial in Hangzhou (Tenofovir Alafenamide Tablets)
Recruiting
- Chronic Hepatitis b
- Tenofovir Alafenamide Fumarate
- Tenofovir Alafenamide Tablets
-
Hangzhou, Zhejiang, ChinaHangzhou First People's Hospital
May 8, 2023
Nephrolithiasis Trial in New York (Thulium Fibre Laser, Holmium:Yttrium-Aluminum-Garnet)
Recruiting
- Nephrolithiasis
- Thulium Fibre Laser
- Holmium:Yttrium-Aluminum-Garnet
-
New York, New YorkMount Sinai West
Apr 22, 2022
AIDS Trial (Dolutegravir 50 MG plus lamivudine 300 MG; Dolutegravir/lamivudine (50 MG/300 MG))
Not yet recruiting
- Acquired Immunodeficiency Syndrome
- Dolutegravir 50 MG plus lamivudine 300 MG; Dolutegravir/lamivudine (50 MG/300 MG)
- (no location specified)
Aug 6, 2022
HIV/AIDS Trial in Paris, Chiang Mai (TDF/FTC 300mg/200mg fixed-dose combination tablets, TAF/FTC 25mg/200mg fixed-dose
Not yet recruiting
- HIV/AIDS
- TDF/FTC 300mg/200mg fixed-dose combination tablets
- TAF/FTC 25mg/200mg fixed-dose combination tablets
-
Paris, France
- +1 more
Apr 3, 2023
Risk Reduction Trial in Cape Town (UTRA, UTRA feedback)
Recruiting
- Risk Reduction
- UTRA
- UTRA feedback
-
Cape Town, Western Cape, South AfricaDesmond Tutu Health Foundation, University of Cape Town
May 17, 2022
Osteoporosis, HIV, Menopause Trial in Canada, Italy (tenofovir-alafenamide-emtricitabine, tenofovir-emtricitabine)
Completed
- Osteoporosis
- +2 more
-
Vancouver, British Columbia, Canada
- +6 more
Dec 22, 2022
Human Immunodeficiency Virus Trial in Atlanta (TDF/FTC Dose Schedule for Arm A, TDF/FTC Dose Schedule for Arm B)
Completed
- Human Immunodeficiency Virus
- TDF/FTC Dose Schedule for Arm A
- TDF/FTC Dose Schedule for Arm B
-
Atlanta, GeorgiaHope Clinic
Sep 20, 2022
HIV, Fatty Liver Disease Trial in Madrid (Dolutegravir (DTG) 50 mg/day + Rilpivirine (RPV) 25mg per day, Tenofovir disoproxil
Recruiting
- HIV Infections
- Fatty Liver Disease
- Dolutegravir (DTG) 50 mg/day + Rilpivirine (RPV) 25mg per day
- +2 more
-
Madrid, Spain
- +3 more
Jun 13, 2023
HIV, Weight Gain Trial in Helsinki (gastroscopy)
Not yet recruiting
- HIV Infections
- Weight Gain
- gastroscopy
-
Helsinki, Uusimaa, FinlandInfectious Disease Clinic, Helsinki University Hospital
Apr 6, 2022
HIV Trial in Paris (Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine)
Not yet recruiting
- HIV Infections
- Switch from an INSTI-based regimen to the non INSTI-based regimen combining TDF/3TC/Doravirine
-
Paris, Ile De France, FranceChristine Katlama
Jul 26, 2022
HIV Prevention Trial in Brazil, United States (Immediate Intervention Arm Truvada in the US, Deferred Intervention Arm Truvada
Enrolling by invitation
- HIV Prevention
- Immediate Intervention Arm Truvada in the US
- +5 more
-
San Francisco, California
- +4 more
Aug 30, 2022
Tenofovir Alafenamide Switch Therapy in Chronic Hepatitis B
Not yet recruiting
- Patient Satisfaction
- +3 more
- tenofovir alafenamide (TAF)
- (no location specified)
Oct 15, 2022